ArticleBlood advances2023

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study.

Maria-Luisa Schubert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.